Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention and Treatment of Pyrrolitinib-associated Diarrhea
NCT04736186Phase 3Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- May 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loperamide in diarrhea, sponsored by Tianjin Medical University Cancer Institute and Hospital. Status: unknown.
02
Drugs
loperamide
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT04736186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04736186.